InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,648.40
(
1.01%
)
US TECH 100
19,050.40
(
1.19%
)
Dow Jones
41,563.08
(
0.55%
)
Brent Oil
77.00
(
0.00%
)
Bitcoin
58,907.63
(
-0.11%
)
Post# of 252998
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

floblu14

Send PM Follow Ignore
Followers 22
Posts 3688
Boards Moderated 0
Alias Born 07/20/2006

floblu14

Re: None

Monday, 10/26/2020 7:32:43 AM

Monday, October 26, 2020 7:32:43 AM

Post# of 252998
Revance price target raised to $38 from $35 at Barclays. RVNC Barclays analyst Balaji Prasad raised the firm's price target on Revance to $38 from $35 and keeps an Overweight rating on the shares. The analyst expects to see signs of a broader recovery in Q3 for the U.S. Specialty Pharmaceuticals companies.

Read more at:
https://thefly.com/n.php?id=3181303
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up